Status:
RECRUITING
Evaluation of Maternal & Newborn Health Simulation Lab Centers of Excellence in Nepal
Lead Sponsor:
One Heart Worldwide
Conditions:
Post Partum Hemorrhage
Asphyxia; Fetal
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Postpartum hemorrhage and birth asphyxia are the leading causes of maternal and neonatal mortalities worldwide. Prevention and adequate treatment are, therefore crucial. While Nepal has made significa...
Detailed Description
Post-partum hemorrhage (PPH) and birth asphyxia are significant contributor to maternal and neonatal mortalities globally. Postpartum hemorrhage leads to around 70,000 deaths, mostly in low and middle...
Eligibility Criteria
Inclusion
- All women who have recently delivered in the study hospital via vaginal delivery
- Newborn delivered at the same hospital with gestational age ≥ 37 weeks, birth weight ≥2500 gm, and a fetal heart sound present at the time of admission
- Maternal and Newborn Health staff working in selected hospitals for at least 3 months
Exclusion
- Women with Postpartum Hemorrhage (PPH) referred from other hospital, babies born outside of study hospital, and newborns with congenital abnormalities will be excluded.
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
1464 Patients enrolled
Trial Details
Trial ID
NCT06577922
Start Date
May 1 2024
End Date
July 31 2026
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Paropakar Maternity and Women's Hospital, Koshi Hospital, Narayani Hospital, Province Hospital Surkhet, BPKIHS, Pokhara Academy of health sciences, and Madhesh Institute of Health Sciences
Kathmandu, Bagmati, Nepal, 44700